The Scientist - Home

Sidebar: Ethics Journals The rise in bioethics centers, courses, and degree programs within the last decade has spawned an expansion in the literature devoted to the subject. According to scientists and ethicists, this is exemplified by an upswing in the number of periodicals and, particularly, individual articles in peer-reviewed publications. This new literature genre covers such areas as scientific fraud and integrity; patients' rights; informed consent; genetic screening; and the disseminat

A sampling of relatively new journals related to science, medical, and engineering ethics that have started in the past seven years: Cambridge Quarterly Journal of Healthcare Ethics Cambridge Univeristy Press 40 W. 20th St., New York, N.Y. 10011-4211 Tel: (212) 924-3900 Fax: (212) 691-3239 E-mail: journals_marketing@cup.org http://www.cup.org First issue published in 1992 Ethics and Behavior Lawrence Erlbaum Associates Inc. 10 Industrial Ave., Mahwah, N.J. 07430 Tel: (201) 236-9500 Fax: (201)

Nobel laureate David Baltimore will assume the presidency of the California Institute of Technology this fall. Baltimore, 59, tells The Scientist he is leaving his post as a professor of molecular biology and immunology at the Massachusetts Institute of Technology, where he has been since 1994, because Caltech is "one of the premier scientific organizations in the world." Baltimore's tenure as president of Rockefeller University in New York lasted just 18 months; he resigned in late 1991 in the

MULTIDISCIPLINARY APPROACH: Researchers who understand "'nouveau technologies' of biology" are needed to develop allergy treatments, notes Hoechst Marion Roussel’s Martin Wasserman. It happens like clockwork: allergy season. Every spring, more than 20 million Americans sneeze, wheeze, and curse the flowers. But if scientists have their way, things might be different in the years to come. Across the United States, biotech and university labs are unraveling the basic biochemistry behind al

Photo: Youngblood PLAY IT AGAIN: Replication is the key to reducing inadvertent errors or fraudulent results, maintains USC's W. French Anderson. Last fall, Francis Collins, a prolific and widely respected scientist, retracted all or parts of five papers he had coauthored in the preceding two years. Collins, the director of the National Center for Human Genome Research at the National Institutes of Health-which in January became the National Human Genome Research Institute-apparently was the v

EQUITY EQUALS SUCCESS: Universities can help start-up ventures by reducing demands for cash, explains licensing officer Mike Martin. A recently issued report has provided new evidence that federal support of basic research in universities earns significant paybacks in the form of jobs created and taxes paid by companies created to exploit research findings. Many institutions have been convinced that they could successfully stimulate start-up companies without losing their academic purity and c

Sidebars Malaria: A Statistical Index Funding Agencies For Malaria Research Researchers in the field lament what they call gross underfunding, but say a joint approach will help ensure that avaliable monies are well spent. After several years of declining interest in malaria research and decreasing support for such studies, the field is gaining much-needed momentum. Spurred in part by an international conference held in Dakar, Senegal, in January, funding agencies and scientists around the gl

Citing numerous safety concerns, the U.S. Department of Energy (DOE) on May 1 announced it is dismissing the company that manages its beleaguered Brookhaven National Laboratory on Long Island, N.Y. Associated Universities Inc. (AUI), Brookhaven's contractor for 50 years, failed to address the department's "needs and expectations for community relations and environment safety and health stewardship," according to a DOE statement. Such a move is unprecedented for DOE, but Secretary of Energy Fede

MALARIA: A STATISTICAL INDEX Date: May 12, 1997 Number of clinical cases per year: 300 million to 500 million Number of deaths per year: 1.5 million to 2.7 million, about 4 percent to 5 percent of all fatalities Rank among major infectious diseases in mortality rates: 3rd (after pneumococcal acute respiratory infections and tuberculosis) Occurrence: 90 percent of all cases in sub-Saharan Africa; two-thirds of remaining cases in six countries: India, Brazil, Sri Lanka, Vi

FUNDING AGENCIES FOR MALARIA RESEARCH Date: May 12, 1997 National Institute of Allergy and Infectious Diseases Contact: Michael Gottlieb or Lee Hall Parasitology and International Programs Branch Solar Building/Room 3A12, Bethesda, Md. 20892-7630 Tel:(301) 496-2544 Fax: (301) 402-0659 E-mail: mg35s@nih.gov (Gottlieb) or bh24q@nih.gov (Hall) Web site: http://www.niaid.nih.gov UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) TDR Communicat

Following fiscal year 1998 congressional appropriations hearings, a budget of about $185 million has been proposed for the Department of Commerce's Advanced Technology Program (ATP), slightly less than the Clinton administration's proposed figure of $275 million. While no one can be sure what the final budget appropriation will be, some observers see the amount as evidence of new bipartisan support for the program, which for the past two years has been dubbed "corporate welfare" and marked for

FORCING THE ISSUE: Thomas Landefeld says his suit against the University of Michigan is an attempt to make it "more responsive to the treatment of minorities on their campus." Thomas Landefeld, a former associate professor of pharmacology, has sued the University of Michigan in Ann Arbor, charging that he was retaliated against-and eventually fired-because of his outspoken attempts to improve the racial environment at Michigan's medical school. Landefeld is currently a professor of biology and